secondary prevention

81 Achieving target LDL-cholesterol levels post acs with lipid lowering therapy & the impact of a nurse-led post-PCI clinic
Colin Mootoo, Sam Holkar, Judy Jinoy, Chih Wong, Ahmed El-Medany, Shahid Aziz, Andrew Skyrme-Jones, Victoria Ruszala, Amardeep Dastidar

Heart Jun 2023, 109 (Suppl 3) A90; DOI: 10.1136/heartjnl-2023-BCS.81
204 The role of the vascular risk modification clinic in achieving guideline-directed lipid lowering therapy: a single-centre observational study
Rahul Chattopadhyay, Vassilios Vassiliou, Joanna Henderson, Peter Pugh, Unni Krishnan, Doris Pretty, Rahul Herlekar, Silvia De Dominicis, Max Brennan

Heart Jun 2023, 109 (Suppl 3) A239-A240; DOI: 10.1136/heartjnl-2023-BCS.204
206 Lipid lowering therapy in patients with incidental coronary artery calcification: a single-centre observational study
Rahul Chattopadhyay, Unni Krishnan, Max Brennan, Maria Wetscherek

Heart Jun 2023, 109 (Suppl 3) A241; DOI: 10.1136/heartjnl-2023-BCS.206
170 Audit on the management of dyslipidaemia in patients presenting with acute myocardial infarction as per esc guidance in a district general hospital - are we meeting targets?
Alice Wong, Yusif Shakanti, Ella Porter, Rebecca Naish, David Lai

Heart Jun 2022, 108 (Suppl 1) A133-A134; DOI: 10.1136/heartjnl-2022-BCS.170
177 A clinical service evaluation investigating how lipid, glycaemic and blood pressure control impacts the long-term cardiovascular outcomes of patients at risk of recurrent acute coronary syndrome
Tanisha Burgher, Alexander James, Aaron Wong

Heart Jun 2022, 108 (Suppl 1) A138; DOI: 10.1136/heartjnl-2022-BCS.176
Sex disparity in subsequent outcomes in survivors of coronary heart disease
Ralph Kwame Akyea, Evangelos Kontopantelis, Joe Kai, Stephen F Weng, Riyaz S Patel, Folkert W Asselbergs, Nadeem Qureshi

Heart Jan 2022, 108 (1) 37-45; DOI: 10.1136/heartjnl-2021-319566
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment
D M Pickin, C J McCabe, L E Ramsay, N Payne, I U Haq, W W Yeo, P R Jackson

Heart Sep 1999, 82 (3) 325-332; DOI: 10.1136/hrt.82.3.325
Population implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health survey
I U Haq, L E Ramsay, E J Wallis, C G Isles, L D Ritchie, P R Jackson

Heart Sep 2001, 86 (3) 289-295; DOI: 10.1136/heart.86.3.289
Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care
N C Campbell, L D Ritchie, J Thain, H G Deans, J M Rawles, J L Squair

Heart Nov 1998, 80 (5) 447-452; DOI: 10.1136/hrt.80.5.447
Lifestyle modification in older versus younger patients with coronary artery disease
Patricia Jepma, Harald T Jorstad, Marjolein Snaterse, Gerben ter Riet, Hans Kragten, Sangeeta Lachman, Madelon Minneboo, S Matthijs Boekholdt, Ron J Peters, Wilma Scholte op Reimer

Heart Jul 2020, 106 (14) 1066-1072; DOI: 10.1136/heartjnl-2019-316056

Main menu

secondary prevention

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

secondary prevention

Pages